SM
Sabby Management Portfolio holdings
AUM
$13M
This Quarter Return
-0.51%
1 Year Return
-26.95%
3 Year Return
-56.43%
5 Year Return
-61.92%
10 Year Return
-71.17%
AUM
$168M
AUM Growth
+$168M
(-6.4%)
Cap. Flow
+$6.38M
Cap. Flow
% of AUM
3.81%
Top 10 Holdings %
Top 10 Hldgs %
57.53%
Holding
165
New
42
Increased
15
Reduced
19
Closed
25
Top Buys
| 1 |
Teva Pharmaceuticals
TEVA
|
$17.5M |
| 2 |
MannKind Corp
MNKD
|
$15.6M |
| 3 |
TWTR
Twitter, Inc.
TWTR
|
$4.6M |
| 4 |
Arbutus Biopharma
ABUS
|
$4.14M |
| 5 |
Acadia Pharmaceuticals
ACAD
|
$3.26M |
Top Sells
| 1 |
Vertex Pharmaceuticals
VRTX
|
$25.5M |
| 2 |
AEGR
Aegerion Pharmaceuticals, Inc.
AEGR
|
$10.1M |
| 3 |
Gilead Sciences
GILD
|
$5.78M |
| 4 |
AGEN
Agenus
AGEN
|
$4.89M |
| 5 |
Novavax
NVAX
|
$4.34M |
Sector Composition
| 1 | Healthcare | 85.48% |
| 2 | Communication Services | 2.75% |
| 3 | Materials | 0.4% |
| 4 | Energy | 0% |
| 5 | Financials | 0% |
